Update on Adult Immunizations

Wolfe, Robert M.

doi:10.3122/jabfm.2012.04.100274

Cited by 15 publications

(6 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, adults, and particularly the elderly have a lower response rate to hepB immunization than do young children (47). HepB immunization of the elderly (> 60) is not recommended given its lack of cost-effectiveness (48). Standard medical practices and health education are effective ways to block transmission from health care workers to patients.…”

Section: Hepb Immunization and Standard Medical Practices For Health mentioning

confidence: 99%

“…HepB immunization of diabetics (type 1 and type 2 diabetes) is generally a key prevention strategy in developing countries where hepB is endemic (37,38). Diabetes patients who are under age 60 should be immunized with the hepB vaccine as soon after they are diagnosed as possible (39). In China, immunization with the hepB vaccine is now voluntary for high-risk patients such as diabetics.…”

Section: Preventive Strategies For Health Care Workers and High-risk mentioning

confidence: 99%

See 1 more Smart Citation

Strategies to prevent hepatitis B virus infection in China: Immunization, screening, and standard medical practices

2013

View full text Add to dashboard Cite

Section: Hepb Immunization and Standard Medical Practices For Health mentioning

confidence: 99%

Section: Preventive Strategies For Health Care Workers and High-risk mentioning

confidence: 99%

Strategies to prevent hepatitis B virus infection in China: Immunization, screening, and standard medical practices

2013

View full text Add to dashboard Cite

“…On the other hand, the virus mutates in a short time and the vaccine made for the new virus will not work [5]. Also the cost of vaccine production is very high, while some studies have emphasized the ineffectiveness of the vaccine in the diseases [6,7,8]. Another disadvantage of vaccination is the large volume of hospital services to cover all members of society [9,10,11].…”

Section: • Coronavirusmentioning

confidence: 99%

An Economic Health Study for Treatment on COVID-19 Disease

badi¹,

Rahbar²,

Nazem³

et al. 2020

Preprint

View full text Add to dashboard Cite

In this paper, drug treatment and vaccination are compared healthy and economically. In this comparison, in addition to comparing economic costs, it has paid attention to patients' recovery. To reach the goal, the prevalence of Covid-19 virus in New York is modeled by using the SEIR dynamic model. The SEIR dynamic model is used to model the period of epidemic diseases. Then, three disease control scenarios are evaluated economically. Treatment and vaccination are two important issues in controlling epidemic diseases. To control the disease, each of these two methods has economic costs and benefits. The main purpose of this paper is to compare the two methods of vaccination and treatment economically. Although the results of the study show that vaccination can be effective in preventing the epidemic of the disease than treatment, but due to the high cost and genetic mutation of the virus, vaccination is not the optimal method for both health and the economy in the long term.

show abstract

“…Numerous professional organizations, including the American Academy of Family Physicians (AAFP) and American Academy of Pediatrics (AAP), have issued position statements endorsing ACIP guidance (Wolfe, 2012). However, multiple factors may impede implementation of HPV vaccination in practice.…”

Section: Introductionmentioning

confidence: 99%